EdgarLookup

Pursuit Attractions & Hospitality, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Pursuit Attractions & Hospitality, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
2.1%
Profit Margin
Net income ÷ revenue
2.3%
Return on Assets
Net income ÷ assets
0.52x
Debt-to-Equity
Total liabilities ÷ equity
+11.7%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2014 Dec 31, 2014 $1.06B Mar 13, 2015
FY2014 Dec 31, 2013 $953.35M Mar 13, 2015
FY2014 Dec 31, 2012 $1.01B Mar 13, 2015
FY2013 Dec 31, 2011 $942.36M Mar 7, 2014
FY2012 Dec 31, 2010 $844.76M Mar 11, 2013

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $452.42M Feb 25, 2026
FY2025 Dec 31, 2024 $366.49M Feb 25, 2026
FY2025 Dec 31, 2023 $350.29M Feb 25, 2026
FY2024 Dec 31, 2022 $299.33M Mar 17, 2025
FY2023 Dec 31, 2021 $507.34M Mar 1, 2024
FY2022 Dec 31, 2020 $415.44M Feb 28, 2023
FY2019 Dec 31, 2019 $321.33M Feb 26, 2020
FY2019 Sep 30, 2019 $362.49M Feb 26, 2020
FY2019 Jun 30, 2019 $402.28M Feb 26, 2020
FY2019 Mar 31, 2019 $285.59M Feb 26, 2020

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $277.29M Feb 28, 2018
FY2017 Sep 30, 2017 $339.10M Feb 28, 2018
FY2017 Jun 30, 2017 $364.77M Feb 28, 2018
FY2017 Mar 31, 2017 $325.81M Feb 28, 2018
FY2017 Dec 31, 2016 $256.40M Feb 28, 2018
FY2017 Sep 30, 2016 $382.47M Feb 28, 2018
FY2017 Jun 30, 2016 $324.75M Feb 28, 2018
FY2017 Mar 31, 2016 $241.36M Feb 28, 2018
FY2016 Dec 31, 2015 $251.67M Mar 6, 2017
FY2016 Sep 30, 2015 $255.95M Mar 6, 2017

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $22.67M Feb 25, 2026
FY2025 Dec 31, 2024 $368.54M Feb 25, 2026
FY2025 Dec 31, 2023 $16.02M Feb 25, 2026
FY2024 Dec 31, 2022 $23.22M Mar 17, 2025
FY2023 Dec 31, 2021 ($92.66M) Mar 1, 2024
FY2020 Dec 31, 2020 ($50.47M) Mar 2, 2021
FY2020 Sep 30, 2020 ($30.76M) Mar 2, 2021
FY2020 Jun 30, 2020 ($206.28M) Mar 2, 2021
FY2020 Mar 31, 2020 ($86.59M) Mar 2, 2021
FY2020 Dec 31, 2019 ($5.43M) Mar 2, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 $108.44M Mar 1, 2024
FY2023 Dec 31, 2022 $68.94M Mar 1, 2024
FY2023 Dec 31, 2021 ($47.00M) Mar 1, 2024
FY2022 Dec 31, 2020 ($116.24M) Feb 28, 2023
FY2020 Dec 31, 2019 $79.45M Mar 2, 2021
FY2018 Dec 31, 2018 $966.0K Feb 27, 2019
FY2018 Sep 30, 2018 $52.60M Feb 27, 2019
FY2018 Jun 30, 2018 $35.24M Feb 27, 2019
FY2018 Mar 31, 2018 ($13.37M) Feb 27, 2019
FY2018 Dec 31, 2017 ($6.59M) Feb 27, 2019

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $80.09M Feb 25, 2026
FY2025 Dec 31, 2024 $57.80M Feb 25, 2026
FY2025 Dec 31, 2023 $56.76M Feb 25, 2026

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 $104.68M Mar 1, 2024
FY2023 Dec 31, 2022 $73.43M Mar 1, 2024
FY2023 Dec 31, 2021 ($37.85M) Mar 1, 2024
FY2022 Dec 31, 2020 ($80.25M) Feb 28, 2023
FY2021 Dec 31, 2019 $108.14M Feb 25, 2022
FY2020 Dec 31, 2018 $90.60M Mar 2, 2021
FY2019 Dec 31, 2017 $112.22M Feb 26, 2020
FY2018 Dec 31, 2016 $100.32M Feb 27, 2019
FY2017 Dec 31, 2015 $60.28M Feb 28, 2018
FY2016 Dec 31, 2014 $58.09M Mar 6, 2017

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $965.43M Feb 25, 2026
FY2025 Dec 31, 2024 $845.01M Feb 25, 2026
FY2024 Dec 31, 2023 $1.14B Mar 17, 2025
FY2023 Dec 31, 2022 $1.09B Mar 1, 2024
FY2022 Dec 31, 2021 $1.04B Feb 28, 2023
FY2021 Dec 31, 2020 $853.22M Feb 25, 2022
FY2021 Dec 31, 2019 $1.32B Feb 25, 2022
FY2020 Dec 31, 2018 $922.54M Mar 2, 2021
FY2019 Dec 31, 2017 $919.90M Feb 26, 2020
FY2018 Dec 31, 2016 $869.82M Feb 27, 2019

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $305.04M Feb 25, 2026
FY2025 Dec 31, 2024 $228.32M Feb 25, 2026
FY2024 Dec 31, 2023 $867.38M Mar 17, 2025
FY2023 Dec 31, 2022 $855.96M Mar 1, 2024
FY2022 Dec 31, 2021 $807.76M Feb 28, 2023
FY2021 Dec 31, 2020 $545.13M Feb 25, 2022
FY2020 Dec 31, 2019 $765.29M Mar 2, 2021
FY2019 Dec 31, 2018 $466.08M Feb 26, 2020
FY2018 Dec 31, 2017 $470.31M Feb 27, 2019
FY2017 Dec 31, 2016 $499.18M Feb 28, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $581.83M Feb 25, 2026
FY2025 Dec 31, 2024 $525.83M Feb 25, 2026
FY2024 Dec 31, 2023 $43.43M Mar 17, 2025
FY2023 Dec 31, 2022 $14.53M Mar 1, 2024
FY2022 Dec 31, 2021 $6.28M Feb 28, 2023
FY2021 Dec 31, 2020 $95.96M Feb 25, 2022
FY2020 Dec 31, 2019 $467.50M Mar 2, 2021
FY2019 Dec 31, 2018 $436.21M Feb 26, 2020
FY2018 Dec 31, 2017 $429.13M Feb 27, 2019
FY2017 Dec 31, 2016 $357.36M Feb 28, 2018

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $150.41M Feb 25, 2026
FY2025 Dec 31, 2024 $103.32M Feb 25, 2026
FY2024 Dec 31, 2023 $123.91M Mar 17, 2025
FY2023 Dec 31, 2022 $121.43M Mar 1, 2024
FY2022 Dec 31, 2021 $112.08M Feb 28, 2023
FY2021 Dec 31, 2020 $99.85M Feb 25, 2022
FY2021 Dec 31, 2019 $287.98M Feb 25, 2022
FY2020 Dec 31, 2018 $261.33M Mar 2, 2021
FY2019 Dec 31, 2017 $270.55M Feb 26, 2020
FY2018 Dec 31, 2016 $254.02M Feb 27, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $57.25M Feb 25, 2026
FY2025 Dec 31, 2024 $33.70M Feb 25, 2026
FY2024 Dec 31, 2023 ($326.08M) Mar 17, 2025
FY2023 Dec 31, 2022 ($334.30M) Mar 1, 2024
FY2022 Dec 31, 2021 ($349.72M) Feb 28, 2023
FY2021 Dec 31, 2020 ($253.16M) Feb 25, 2022
FY2020 Dec 31, 2019 $122.97M Mar 2, 2021
FY2019 Dec 31, 2018 $109.03M Feb 26, 2020
FY2018 Dec 31, 2017 $65.84M Feb 27, 2019
FY2017 Dec 31, 2016 $16.29M Feb 28, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $31.12M Feb 25, 2026
FY2025 Dec 31, 2024 $49.70M Feb 25, 2026
FY2024 Dec 31, 2023 $27.44M Mar 17, 2025
FY2023 Dec 31, 2022 $59.72M Mar 1, 2024
FY2022 Dec 31, 2021 $61.60M Feb 28, 2023
FY2021 Dec 31, 2020 $39.55M Feb 25, 2022
FY2020 Dec 31, 2019 $62.00M Mar 2, 2021
FY2019 Dec 31, 2018 $44.89M Feb 26, 2020
FY2018 Dec 31, 2017 $53.72M Feb 27, 2019
FY2018 Dec 31, 2016 $20.90M Feb 27, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $99.26M Feb 25, 2026
FY2025 Dec 31, 2024 $15.02M Feb 25, 2026
FY2024 Dec 31, 2023 $388.75M Mar 17, 2025
FY2023 Dec 31, 2022 $400.20M Mar 1, 2024
FY2022 Dec 31, 2021 $390.45M Feb 28, 2023
FY2022 Dec 31, 2020 $400.20M Feb 28, 2023
FY2020 Dec 31, 2019 $315.24M Mar 2, 2021
FY2019 Dec 31, 2018 $225.48M Feb 26, 2020
FY2017 Dec 31, 2017 $207.32M Feb 28, 2018
FY2017 Dec 31, 2016 $212.75M Feb 28, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Feb 25, 2026
FY2025 Dec 31, 2024 12 Feb 25, 2026
FY2025 Dec 31, 2023 0 Feb 25, 2026
FY2024 Dec 31, 2022 0 Mar 17, 2025
FY2023 Dec 31, 2021 (5) Mar 1, 2024
FY2022 Dec 31, 2020 (18) Feb 28, 2023
FY2021 Dec 31, 2019 1 Feb 25, 2022
FY2020 Dec 31, 2018 2 Mar 2, 2021
FY2019 Dec 31, 2017 2 Feb 26, 2020
FY2018 Dec 31, 2016 2 Feb 27, 2019

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Feb 25, 2026
FY2025 Dec 31, 2024 12 Feb 25, 2026
FY2025 Dec 31, 2023 0 Feb 25, 2026
FY2024 Dec 31, 2022 0 Mar 17, 2025
FY2023 Dec 31, 2021 (5) Mar 1, 2024
FY2020 Dec 31, 2020 (2) Mar 2, 2021
FY2020 Sep 30, 2020 (1) Mar 2, 2021
FY2020 Jun 30, 2020 (10) Mar 2, 2021
FY2020 Mar 31, 2020 (4) Mar 2, 2021
FY2020 Dec 31, 2019 0 Mar 2, 2021

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 28.01M Feb 25, 2026
FY2025 Dec 31, 2024 28.08M Feb 25, 2026
FY2024 Dec 6, 2024 28.00M Mar 17, 2025
FY2024 Dec 31, 2023 28.08M Mar 17, 2025
FY2023 Dec 31, 2022 24.93M Mar 1, 2024
FY2022 Dec 31, 2021 24.93M Feb 28, 2023
FY2021 Dec 31, 2020 24.93M Feb 25, 2022
FY2020 Dec 31, 2019 24.93M Mar 2, 2021
FY2019 Dec 31, 2018 24.93M Feb 26, 2020
FY2018 Dec 31, 2017 24.93M Feb 27, 2019

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 $0 Feb 28, 2023
FY2022 Dec 31, 2021 $0 Feb 28, 2023
FY2022 Dec 31, 2020 $4.06M Feb 28, 2023
FY2021 Dec 31, 2019 $8.09M Feb 25, 2022
FY2020 Dec 31, 2018 $8.15M Mar 2, 2021
FY2019 Dec 31, 2017 $8.16M Feb 26, 2020
FY2018 Dec 31, 2016 $8.11M Feb 27, 2019
FY2017 Dec 31, 2015 $8.04M Feb 28, 2018
FY2016 Dec 31, 2014 $38.39M Mar 6, 2017
FY2015 Dec 31, 2013 $58.91M Mar 11, 2016